Canada Diabetes Care Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Canada Diabetes Care Devices Market is segmented into management devices (insulin pumps, insulin syringes, disposable insulin pens, insulin cartridges in reusable pens, and insulin jet injectors) and monitoring devices (self-monitoring blood glucose (glucometer devices, test strips, and lancets) and continuous glucose monitoring (sensors and receivers (receivers and transmitters))). The report offers the value (in USD million) and volume (in units million) for the above segments.

Canada Diabetes Care Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Canada Diabetes Care Devices Market Size

View Global Report
Canada Diabetes Devices Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
Market Size (2025) USD 2.03 Billion
Market Size (2030) USD 2.58 Billion
CAGR (2025 - 2030) 4.98 %

Major Players

Canada Diabetes Care Devices Market  Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Canada Diabetes Care Devices Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Canada Diabetes Care Devices Market Analysis

The Canada Diabetes Care Devices Market size is estimated at USD 2.03 billion in 2025, and is expected to reach USD 2.58 billion by 2030, at a CAGR of 4.98% during the forecast period (2025-2030).

Canada has 107,861 cases of coronavirus disease 2019 (COVID-19) (286 per 1,00,000 individuals) and 8787 COVID-19-related fatalities as of July 13, 2020. In Canada, public health is overseen at the federal, provincial, and regional levels, and the Canadian constitution delegates healthcare authority to the country's ten provinces and three territories. As a result, similar to the United States, where individual states generally defined the COVID-19 response, Canadian provinces have mostly selected containment and mitigation plans. Provincial public health authorities collaborated closely with regional public health officers and municipal governments to develop policies and recommendations, as well as to put services like testing and contact tracing in place. Blood pressure regulation is a critical component of diabetes management. Furthermore, even in the absence of high blood pressure, certain blood pressure lowering medications are frequently recommended for people living with diabetes to protect them from kidney and heart-related complications. There is currently no scientific evidence linking these blood pressure drugs to the likelihood of COVID-19 infection or associated consequences.

In Canada, During the pandemic, many healthcare providers have adopted a hybrid model of care, offering certain types of visits in-person at the clinic and others virtually, by phone, video chat, or secure messaging. Virtual diabetes care may be a new and different experience for you. For tips on preparing for your diabetes visit and managing virtual appointments.

Canada Diabetes Care Devices Industry Overview

The Canada Diabetes Care Devices Market is moderately fragmented, with few significant and other generic players. Manufacturers like Abbott, LifeScan, F. Hoffmann-La Roche AG, Ascensia, etc., occupy a major share.

Canada Diabetes Care Devices Market Leaders

  1. Dexcom

  2. Medtronic

  3. Novo Nordisk A/S

  4. F. Hoffmann-La Roche AG

  5. Abbott Diabetes Care

  6. *Disclaimer: Major Players sorted in no particular order
Canada Diabetes Care Devices Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Canada Diabetes Care Devices Market News

  • July 2022: NuGen Medical Devices Inc. announced that its needle-free injection system and accessories, also known as InsuJet, were approved by Health Canada specifically for needle-free insulin delivery.
  • March 2022: The Ontario government announced that it would provide coverage for the Dexcom G6 CGM System through Ontario's Assistive Devices Program (ADP) for people in the province with type 1 diabetes who are over 2 years of age and meet coverage criteria. The Non-Insured health benefits program also covers first nations and Inuit children. With expanded public coverage for CGM, more people can access this standard care technology, helping them to manage life-long chronic illnesses more effectively.

Canada Diabetes Care Devices Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
  • 4.3 Market Restraints
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 Management Devices
    • 5.1.1 Insulin Pump
    • 5.1.1.1 Insulin Pump Device
    • 5.1.1.2 Insulin Pump Reservoir
    • 5.1.1.3 Infusion Set
    • 5.1.2 Insulin Syringes
    • 5.1.3 Insulin Disposable Pens
    • 5.1.4 Insulin Cartridges in Reusable pens
    • 5.1.5 Insulin Jet Injectors
  • 5.2 Monitoring Devices
    • 5.2.1 Self-monitoring Blood Glucose Devices
    • 5.2.1.1 Glucometer Devices
    • 5.2.1.2 Test Strips
    • 5.2.1.3 Lancets
    • 5.2.2 Continuous Glucose Monitoring
    • 5.2.2.1 Sensors
    • 5.2.2.2 Receivers (Receivers and Transmitters)

6. MARKET INDICATORS

  • 6.1 Type 1 Diabetes Population
  • 6.2 Type 2 Diabetes Population

7. COMPETITIVE LANDSCAPE

  • 7.1 COMPANY PROFILES
    • 7.1.1 Novo Nordisk A/S
    • 7.1.2 Sanofi Aventis
    • 7.1.3 Eli Lilly
    • 7.1.4 F. Hoffmann-La Roche
    • 7.1.5 Abbott Diabetes Care
    • 7.1.6 Lifescan
    • 7.1.7 Arkray
    • 7.1.8 Ascensia Diabetes Care
    • 7.1.9 AgaMatrix Inc.
    • 7.1.10 Dexcom
    • 7.1.11 Medtronic
    • 7.1.12 Ypsomed Holding AG
    • 7.1.13 Terumo
  • *List Not Exhaustive
  • 7.2 COMPANY SHARE ANALYSIS
    • 7.2.1 Self-monitoring Blood Glucose Devices
    • 7.2.1.1 Abbott Diabetes Care
    • 7.2.1.2 F. Hoffmann-La Roche Ltd
    • 7.2.1.3 Others
    • 7.2.2 Continuous Glucose Monitoring Devices
    • 7.2.2.1 Abbott Diabetes Care
    • 7.2.2.2 Medtronic PLC
    • 7.2.2.3 Dexcom
    • 7.2.2.4 Others
    • 7.2.3 Insulin Devices
    • 7.2.3.1 Medtronic PLC
    • 7.2.3.2 Novo Nordisk A/S
    • 7.2.3.3 Others

8. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Canada Diabetes Care Devices Industry Segmentation

Diabetes care devices are the hardware, equipment, and software used by diabetes patients to regulate blood glucose levels, prevent diabetes complications, lessen the burden of diabetes, and enhance the quality of life. The Canada Diabetes Care Devices Market is segmented into management devices (insulin pumps, insulin syringes, disposable insulin pens, insulin cartridges in reusable pens, and insulin jet injectors) and monitoring devices (self-monitoring blood glucose (glucometer devices, test strips, and lancets) and continuous glucose monitoring (sensors and receivers (receivers and transmitters))). The report offers the value (in USD million) and volume (in units million) for the above segments.

Management Devices Insulin Pump Insulin Pump Device
Insulin Pump Reservoir
Infusion Set
Insulin Syringes
Insulin Disposable Pens
Insulin Cartridges in Reusable pens
Insulin Jet Injectors
Monitoring Devices Self-monitoring Blood Glucose Devices Glucometer Devices
Test Strips
Lancets
Continuous Glucose Monitoring Sensors
Receivers (Receivers and Transmitters)
Need A Different Region or Segment?
Customize Now

Canada Diabetes Care Devices Market Research FAQs

How big is the Canada Diabetes Care Devices Market?

The Canada Diabetes Care Devices Market size is expected to reach USD 2.03 billion in 2025 and grow at a CAGR of 4.98% to reach USD 2.58 billion by 2030.

What is the current Canada Diabetes Care Devices Market size?

In 2025, the Canada Diabetes Care Devices Market size is expected to reach USD 2.03 billion.

Who are the key players in Canada Diabetes Care Devices Market?

Dexcom, Medtronic, Novo Nordisk A/S, F. Hoffmann-La Roche AG and Abbott Diabetes Care are the major companies operating in the Canada Diabetes Care Devices Market.

What years does this Canada Diabetes Care Devices Market cover, and what was the market size in 2024?

In 2024, the Canada Diabetes Care Devices Market size was estimated at USD 1.93 billion. The report covers the Canada Diabetes Care Devices Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Canada Diabetes Care Devices Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Canada Diabetes Care Devices Industry Report

Statistics for the 2025 Canada Diabetes Care Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Canada Diabetes Care Devices analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.